EUVIMEDOtkrijte EUVIMED
CrossrefInformacijska kartica

Periodontal Regeneration Related to Periodontitis Treated by Garden Cress and Ozone Therapy. (Randomized Clinical &Experimental Study)

Zienab S. Farid, Doaa Adel Habba, Gihan Adel Balbola, Noura Mohammed Bakr

Journal of Medicine in Scientific Research · 2024-01-01 · 7 (2)

DOI: 10.59299/2537-0928.1066 ↗
SažetakBibliografski podaci

Sažetak

Objective: In this article, garden cress and ozone were evaluated for their potential therapeutic properties of PDL and resorption of alveolar bone in the periodontal tissues based on rats' experimental periodontitis and to assess the clinical effectiveness of local application of garden cress and ozone for treatment and management of periodontitis patients using scaling and root planing. Methodology: Thirty mature Wistar male albino rats. Three groups of rats were formed; periodontitis without treatment, periodontitis with garden cress, and periodontitis plus ozone therapy. The present study also included thirty periodontitis Patients were randomly allocated to one of three groups of ten people each. Group A just had scaling and root planning done; Group B&C received scaling and root planing plus garden cress therapy and ozone therapy respectively . After one month, clinical parameters were recorded. Results: Clinical parameters included clinical attachment level (CAL), probing depth (PD), bleeding on probing (BOP), and plaque index (PI) increased significantly across the research groups (groups B and C) after one month of treatment. It is also showed that garden cress applied topically quickens alveolar bone and PDL repair in albino rats with periodontitis that has been produced, While ozone gel improves osteoplastic activity and new bone production. Conclusion: The use of garden cress and ozone in conjunction with alternative treatments improved the treatment success of periodontitis patients.

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.

Prikaži tarife →